Weining Ma

HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab

Shanu Modi, Alison Stopeck, Hannah Linden et al. · Clinical Cancer Research · 2011 · 418 citations

Combination of Trastuzumab and Tanespimycin (17-AAG, KOS-953) Is Safe and Active in Trastuzumab-Refractory HER-2–Overexpressing Breast Cancer: A Phase I Dose-Escalation Study

Shanu Modi, Alison Stopeck, Michael S. Gordon et al. · Journal of Clinical Oncology · 2007 · 331 citations

A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors

Komal Jhaveri, Kathy D. Miller, Lee S. Rosen et al. · Clinical Cancer Research · 2012 · 71 citations

Microsatellite Instability–High Endometrial Cancers with <i>MLH1</i> Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

Beryl Manning‐Geist, Ying L. Liu, Kelly A. Devereaux et al. · Clinical Cancer Research · 2022 · 59 citations · Full text

Imaging Appearance of Granulomatous Disease After Intravesical Bacille Calmette-Guérin (BCG) Treatment of Bladder Carcinoma

Weining Ma, Stella K. Kang, Hedvig Hricak et al. · American Journal of Roentgenology · 2009 · 44 citations